as on February 21, 2026 at 7:59 am IST
Day's Low
Day's High
0.30%
Downside
0.91%
Upside
52 Week's Low
52 Week's High
45.59%
Downside
3.67%
Upside
Check Gsk Plc-spon Adr. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$122.1B
EPS (TTM)
4.7601
Dividend Yield
3.45%
Quarterly Earnings Growth YOY
0.55%
PE Ratio (TTM)
16.1
Industry PE ratio
21.201666666666668
PEG Ratio
0.3819
EBITDA
13.2B
Revenue (TTM)
32.7B
Profit Margin
17.50%
Return On Equity TTM
43.31%
Track how Gsk Plc-spon Adr. P/E has moved over time to understand its valuation trends.
Gsk Plc-spon Adr. in the last 5 years
Lowest (8.73x)
September 30, 2025
Today (16.10x)
February 21, 2026
Industry (21.20x)
February 21, 2026
Highest (13.53x)
June 30, 2022
Today’s Price to Earnings Ratio: 16.10x
Compare market cap, revenue, PE, and other key metrics of Gsk Plc-spon Adr. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $122.1B | 38.3% | 16.1 | 17.50% | |
| BUY | $965.3B | 402.45% | 44.45 | 31.67% | |
| BUY | $584.2B | 303.64% | 62.59 | 16.17% | |
| BUY | $595.0B | 48.79% | 22.22 | 28.46% | |
| BUY | $396.5B | 114.08% | 95.06 | 6.91% |
The Gsk Plc-spon Adr. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Gsk Plc-spon Adr. investment value today
Current value as on today
₹1,67,131
Returns
₹67,131
(+67.13%)
Returns from Gsk Plc-spon Adr. Stock
₹62,418 (+62.42%)
Dollar Returns*
₹4,713 (+4.71%)
Based on 33 analysts
60.61%
Buy
30.30%
Hold
9.09%
Sell
Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for Gsk Plc-spon Adr.. Average target price of $57.1
Get share price movements and forecasts by analysts on Gsk Plc-spon Adr..
What analysts predicted
-4.22%DOWNSIDE
Target Price
$57.1
Current Price
$59.51
Analyzed by
33 Analysts
Target
$57.10
Gsk Plc-spon Adr. target price $57.1, a slight downside of -4.22% compared to current price of $59.51. According to 33 analysts rating.
Search interest for Gsk Plc-spon Adr. Stock has increased by 60% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:60% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 04 February
Wed, 07:01 PM
-GSK reports Q4 2025 earnings of 68 cents, exceeding estimates, with revenues of $11.46 billion, driven by strong sales in specialty medicines.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, GSK stock has moved up by 22.3%
Against Peers
![]()
In the last 1 year, ASTRAZENECA PLC has given 175.1% return, outperforming this stock by 112.7%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 196.6% return, outperforming this stock by 130.1%
Revenue Fall
![]()
GSK Plc's revenue has experienced a decline over the last two quarters. It decreased from $8.54 billion to $8.50 billion, reflecting an average decrease of 0.5% each quarter.
Profit Down
![]()
GSK Plc's net profit has decreased for the last two quarters, dropping from $2.01 billion to $627.72 million. This represents an average decline of 68.8% per quarter.
| Organisation | Gsk Plc-spon Adr. |
| Headquarters | 79 New Oxford Street, London, United Kingdom, WC1A 1DG |
| Industry | Health Technology |
| CEO | Mr. Luke Victor Miels |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Tony Wood | Chief Scientific Officer and Head of R&D |
Mr. James Ford | Senior VP and Group General Counsel of Legal & Compliance |
Ms. Julie Belita Brown A.C.A. | CFO & Executive Director |
Mr. Luke Victor Miels | CEO & Director |
Mr. Constantin Fest | Senior VP & Head of Investor Relations |
Mr. David Simon Redfern BSc (Hons), CA | President of Corporate Development |
Ms. Diana Conrad | Chief People Officer |
Mr. Philip C. Thomson | President of Global Affairs |
Dr. Jesse L. Goodman M.D., M.P.H. | Scientific & Medical Expert |
Ms. Shobie Ramakrishnan | Chief Digital & Technology Officer |
Gsk Plc-spon Adr. share price today is $59.51 as on at the close of the market. Gsk Plc-spon Adr. share today touched a day high of $60.05 and a low of $59.33.
Gsk Plc-spon Adr. share touched a 52 week high of $61.7 on and a 52 week low of $32.38 on . Gsk Plc-spon Adr. stock price today i.e. is closed at $59.51,which is 3.54% down from its 52 week high and 83.79% up from its 52 week low.
Gsk Plc-spon Adr. market capitalisation is $0.12T as on .
Indian investors can start investing in Gsk Plc-spon Adr. (GSK) shares with as little as ₹90.681 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.81 in Gsk Plc-spon Adr. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Gsk Plc-spon Adr. share’s latest price of $59.51 as on February 21, 2026 at 2:29 am IST, you will get 0.1680 shares of Gsk Plc-spon Adr.. Learn more about
fractional shares .
Gsk Plc-spon Adr. stock has given 38.3% share price returns and 25.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?